Results bivalirudin use in actual practice in patients with acute coronary syndrome during percutaneous coronary intervention

Cover Page

Abstract


Presents the results of the use of Bivalirudin in actual practice in patients with acute coronary syndrome during percutaneous coronary intervention (PCI). Demonstrated high efficiency of Bivalirudin in the amount of bleeding occurring in the postoperative period and adverse cardiovascular complications.

Z H Shugushev

Peoples’ Friendship University of Russia

Email: olyang84@gmail.com
Department of Cardiovascular Surgery

A S Petrov

Peoples’ Friendship University of Russia

Email: olyang84@gmail.com
Department of Cardiovascular Surgery

Ju S Kolzhetsova

Peoples’ Friendship University of Russia

Email: olyang84@gmail.com
Department of Hospital Surgery with the course of pediatric surgery; Central Clinical Hospital № 2 of Joint Stock Company “Russian Railways” n.a. Semashko N.A. Losinoostrovskaya str., 43, Moscow, Russia, 107150

D A Maksimkin

Peoples’ Friendship University of Russia

Email: olyang84@gmail.com
Department of Hospital Surgery with the course of pediatric surgery; Central Clinical Hospital № 2 of Joint Stock Company “Russian Railways” n.a. Semashko N.A. Losinoostrovskaya str., 43, Moscow, Russia, 107150

V Yu Baranovych

Peoples’ Friendship University of Russia

Email: olyang84@gmail.com
Department of Hospital Surgery with the course of pediatric surgery; Central Clinical Hospital № 2 of Joint Stock Company “Russian Railways” n.a. Semashko N.A. Losinoostrovskaya str., 43, Moscow, Russia, 107150

G I Veretnik

Peoples’ Friendship University of Russia

Email: olyang84@gmail.com
Department of Hospital Surgery with the course of pediatric surgery; Central Clinical Hospital № 2 of Joint Stock Company “Russian Railways” n.a. Semashko N.A. Losinoostrovskaya str., 43, Moscow, Russia, 107150

Views

Abstract - 21

PDF (Russian) - 26


Copyright (c) 2014 Шугушев З.Х., Петров А.С., Кольжецова Ю.С., Максимкин Д.А., Баранович В.Ю., Веретник Г.И.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.